×
About 3,385 results

ALLMedicine™ Migraine Headache Center

Research & Reviews  816 results

Migraine treatment with external concurrent occipital and trigeminal neurostimulation-A...
https://doi.org/10.1111/head.14350
Headache Tepper SJ, Grosberg B et. al.

Jun 25th, 2022 - To evaluate the efficacy and safety of concurrent non-invasive stimulation of occipital and trigeminal nerves in acute treatment of migraine with or without aura. Non-invasive neuromodulation devices stimulating a single peripheral nerve or anatom...

New—and surprising—ways to approach migraine pain
https://www.mdedge.com/familymedicine/article/255371/pain/new-and-surprising-ways-approach-migraine-pain
MDedge Family Medicine; John Hickner, MD, MSc

Jun 13th, 2022 - Migraine headaches pose a challenge for many patients and their physicians, so new, effective approaches are always welcome. Sometimes new treatments come as total surprises.

Prospective, Multi-Center Evaluation of the Efficacy of Peripheral Trigger Decompression Surgery for Migraine Headaches
https://clinicaltrials.gov/ct2/show/NCT02351544

Jun 13th, 2022 - According to the peripheral trigger theory of migraine headaches, nociceptive inputs from irritated or compressed cranial nerve branches can lead to neurovascular changes in the brain that cause migraine headaches. Advanced treatments aimed at dea...

Cycling multisensory changes in migraine: more than a headache.
https://doi.org/10.1097/WCO.0000000000001059
Current Opinion in Neurology; Peng KP, May A et. al.

Jun 9th, 2022 - Research on migraine usually focuses on the headache; however, accumulating evidence suggests that migraine not only changes the somatosensory system for nociception (pain), but also the other modalities of perception, such as visual, auditory or ...

see more →

Guidelines  1 results

Evidence-based guideline update: NSAIDs and other complementary treatments for episodic...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335449
Neurology Holland S, Silberstein SD et. al.

Apr 25th, 2012 - To provide updated evidence-based recommendations for the preventive treatment of migraine headache. The clinical question addressed was: Are nonsteroidal anti-inflammatory drugs (NSAIDs) or other complementary treatments effective for migraine pr...

see more →

Drugs  208 results see all →

Clinicaltrials.gov  139 results

Prospective, Multi-Center Evaluation of the Efficacy of Peripheral Trigger Decompression Surgery for Migraine Headaches
https://clinicaltrials.gov/ct2/show/NCT02351544

Jun 13th, 2022 - According to the peripheral trigger theory of migraine headaches, nociceptive inputs from irritated or compressed cranial nerve branches can lead to neurovascular changes in the brain that cause migraine headaches. Advanced treatments aimed at dea...

Study to Assess Adverse Events When Ubrogepant Tablets in Combination With Atogepant Tablets Are Used to Treat Adult Participants With Migraine
https://clinicaltrials.gov/ct2/show/NCT05264129

Jun 7th, 2022 - Migraine is a neurological disease characterized by moderate or severe headache, associated with nausea, vomiting, and/or sensitivity to light and sound. This study will assess the safety and efficacy of the combination use of ubrogepant for the a...

Double-blind, Placebo-controlled Study of BGC20-1531 in Migraine
https://clinicaltrials.gov/ct2/show/NCT00888680

Jun 3rd, 2022 - Migraine headache is estimated to affect 10-20% of the world population and is listed by the World Health Organisation in the top 20 causes of disabling conditions, and in the top four neurological disabling conditions. The most common therapies f...

Efficacy and Safety of Tx360® Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Migraine
https://clinicaltrials.gov/ct2/show/NCT03337620

Jun 1st, 2022 - This is a phase III, multi-center, randomized, double-blind, placebo-controlled, prospective, clinical trial examining the outcomes of subjects with chronic migraine headache who are treated with 0.3cc of 0.5% bupivacaine bilaterally vs 0.3cc of s...

GORE® CARDIOFORM Septal Occluder Migraine Clinical Study
https://clinicaltrials.gov/ct2/show/NCT04100135

Jun 1st, 2022 - Multi-center, prospective, randomized, placebo- and sham-controlled study to evaluate the GORE® CARDIOFORM Septal Occluder for migraine headache relief

see more →

News  186 results

New—and surprising—ways to approach migraine pain
https://www.mdedge.com/familymedicine/article/255371/pain/new-and-surprising-ways-approach-migraine-pain
MDedge Family Medicine; John Hickner, MD, MSc

Jun 13th, 2022 - Migraine headaches pose a challenge for many patients and their physicians, so new, effective approaches are always welcome. Sometimes new treatments come as total surprises.

The Slow, Long Search for Migraine’s Headwaters
https://www.mdedge.com/migraine-icymi/article/255129/headache-migraine/slow-long-search-migraines-headwaters
Faisal Mohammad Amin, MD, PhD, and Messoud Ashina, MD, PhD

Jun 3rd, 2022 - Dr. Messoud Ashina is a Professor of Neurology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.

Managing Migraine in Primary Care: 5 Things to Know
https://www.medscape.com/viewarticle/971994

Apr 25th, 2022 - Globally, migraine is second among leading causes of years lived with disability. Migraine affects about 15% of the US population and is one of the most common and debilitating conditions encountered by primary care providers (PCPs). About 1 in 10...

Retro-orbital headache and nausea
https://www.mdedge.com/migraine-challenge-center/article/253939/migraine/retro-orbital-headache-and-nausea

Apr 21st, 2022 - On the basis of his presentation, this patient is probably experiencing migraine with visual aura. Migraine is a condition in children and adolescents whose prevalence increases with age: 1%-3% between age 3 and 7 years, 4%-11% between age 7 and 1.

Psychiatric comorbidities highly prevalent in children hospitalized with migraine
https://www.mdedge.com/migraine-challenge-center/article/253094/migraine/psychiatric-comorbidities-highly-prevalent

Mar 24th, 2022 - Key clinical point: Children hospitalized with migraine showed a high prevalence of psychiatric comorbidities, the presence of which was associated with increased medication use, a longer length of stay (LOS), and increased readmission. Major find.

see more →

Patient Education  4 results see all →